Impact of Breast Shield Designs on Dynamics of Breast Pumping
BSD
1 other identifier
interventional
15
1 country
1
Brief Summary
A prospective, randomized, 2-phase/crossover, single center premarket feasibility study. In phase I the comfort will be assessed, the occurence and types of adverse events will be recorded and the assessment how and if the different breast shield designs interact with the lacting breast during pumping. Phase II takes place at home; assessment of adverse events will be recorded and the assessment how the subjects perceives the comfort of the soft edge breast shield during mid term use at home.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 12, 2016
CompletedFirst Posted
Study publicly available on registry
March 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedFebruary 10, 2020
April 1, 2016
2 months
February 12, 2016
February 7, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Endpoint Phase 1_Optical analysis via photo: pumping sessions of the nipple and breast will be video recorded from the lateral side view; study set up will be filmed and the audio data taken to document all the information
During all three short pumping sessions the nipple and breast will be video recorded from the lateral side view. The study set up will be filmed and the audio data taken to document all the information e.g. nipple movement in the tunnel.
End of phase I (is defined from the date when moms are coming for Phase I, which takes up to 2 weeks. But the visit itself per mom takes approx. 2hours)
Endpoint Phase 1_Retrospective analysis via Video: by changing the shape of the breast shield the form of the breast shield will better suit and conform to the breast shape
It is theorized that by changing the shape of the breast shield the form of the breast shield will better suit and conform to the breast shape, improving comfort, reducing any point compression against the skin surface, and supporting freedom of movement of the nipple in the tunnel. During all three short pumping sessions the nipple and breast will be video recorded from the lateral side view. The study set up will be filmed and the audio data taken to document all the information e.g. nipple movement in the tunnel. Retrospective analysis will be undertaken of the recorded videos. The videos will be analyzed using software for a Desktop Ruler. Characteristics of nipple movement in the tunnel during pumping/Amount of tissue entering the tunnel at max.applied vacuum(mm)/Amount of tissue entering the tunnel at min.applied vacuum(mm)/Space between breast and shield(mm)
End of phase I (is defined from the date when moms are coming for Phase I, which takes up to 2 weeks. But the visit itself per mom takes approx. 2hours)
Endpoint Phase 1_ Questionnaire: After pumping with all 3 breast shields participants will be asked questions about comfort perception, handling experience and the sensation per shield.
After pumping with all 3 breast shields participants will be asked questions about comfort perception, handling experience and the sensation per shield.
End of phase I (is defined from the date when moms are coming for Phase I, which takes up to 2 weeks. But the visit itself per mom takes approx. 2hours)
Secondary Outcomes (2)
Endpoint Phase 2_Pump log and questionnaires: will be asked to document each breast milk expression in the pump log.A questionnaire needs to be completed by the end of each week for the used breast shield
End of phase II (Phase II takes place for 2 weeks at moms home; the end is defined as 4 weeks after end of phase I)
Endpoint Phase 2_Collection of AEs, if any: To assess which adverse events occurred during the home-test by completing the AE form
End of phase II (Phase II takes place for 2 weeks at moms home; the end is defined as 4 weeks after end of phase I)
Study Arms (3)
Breastshield treatment group A
EXPERIMENTALParticipants will be treated with the following three breast shields: Soft edge oval - Hard oval - Modified PF breast shield Treatment order is described in the corresponding Intervention. Participant will use each breastshield for 2 min after milk ejection.
Breastshield treatment group B
EXPERIMENTALParticipants will be treated with the following three breast shields: Modified PF breast shield - Soft edge oval - Hard oval Treatment order is described in the corresponding Intervention. Participant will use each breastshield for 2 min after milk ejection.
Breastshield treatment group C
EXPERIMENTALParticipants will be treated with the following three breast shields: Hard oval - Soft edge oval - Modified PF breast shield Treatment order is described in the corresponding Intervention. Participant will use each breastshield for 2 min after milk ejection.
Interventions
Treatment order: 1. soft-edge oval breast shield 2. Hard oval breast shield 3. modified PersonalFit breast shield
1. modified PersonalFit breast shield 2. soft-edge oval breast shield 3. Hard oval breast shield
1. Hard oval breast shield 2. soft-edge oval breast shield 3. modified PersonalFit breast shield
Eligibility Criteria
You may qualify if:
- Female over 18 years
- The participant agrees to pump or feed the last time a minimum of 3 hours before the start of the pumping sessions (phase 1)
- The participant agrees to photograph and video record the breast and upper body (no face) as well as to take audio data.
- Participant agrees to the presence of up to 3 men in the room during the pumping session
- The participant has been pumping at least 7 times in the week prior to study participation, no matter which electric pumps.
- The participant has been consistently pumping 10 ml of milk or more per breast, per pumping session prior to study participation.
- The participant currently use a breast shield size of 24 mm
- The participant has agreed to pump at least 7 times a week over the next three weeks
You may not qualify if:
- \- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medela AGlead
Study Sites (1)
Medela AG
Baar, Canton of Zug, 6340, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Danielle Prime, PhD
Medela AG, Lättichstrasse 4b, 6340 Baar
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2016
First Posted
March 25, 2016
Study Start
February 1, 2016
Primary Completion
April 1, 2016
Study Completion
April 1, 2016
Last Updated
February 10, 2020
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share